Skip to main content
Log in

Perioperative Gabe von Acetylsalicylsäure vermindert nicht das Herzinfarktrisiko bei Patienten mit kardiovaskulären Vorerkrankungen

Perioperative administration of aspirin does not reduce the risk of cardiac infarction in patients with pre-existing cardiovascular diseases

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Devereaux PJ, POISE-2 Investigators (2014) Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J 167:804–809

    Article  PubMed  CAS  Google Scholar 

  2. Devereaux PJ, Mrkobrada M, Sessler DI et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503

    Article  PubMed  CAS  Google Scholar 

  3. Pulmonary Embolism Prevention (PEP) trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295–1302

    Article  Google Scholar 

  4. Antithrombotic Trialists‘ (ATT), C, Baigent C, Blackwell L et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849–1860

    Article  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C. Perioperative Gabe von Acetylsalicylsäure vermindert nicht das Herzinfarktrisiko bei Patienten mit kardiovaskulären Vorerkrankungen. Kardiologe 8, 364–365 (2014). https://doi.org/10.1007/s12181-014-0608-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0608-6

Navigation